Paper ยท 21984977
Functional viability profiles of breast cancer.
Brough R and 21 others. Cancer Discov, 2011. Cited by 123 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Functional viability profiles of breast cancer. Papers, record 21984977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21984977
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Cell Line, Tumor | |
| Female | |
| Gene Expression Profiling | |
| Genetic Testing | |
| Humans | |
| M Phase Cell Cycle Checkpoints | |
| Mutation | |
| PTEN Phosphohydrolase | |
| Protein Kinases | |
| Receptors, Estrogen |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 11566 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| A8363 | Cancer Research UK | United Kingdom | PubMed | PubMed | |
| BREAST CANCER NOW RESEARCH CENTRE | Breast Cancer Now | United Kingdom | PubMed | PubMed | |
| P30 CA082103 | NCI NIH HHS | United States | P30CA082103 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 22,586,571 | Functional subtyping of breast cancer. | https://conductscience.org/library/papers/22586571 |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,838,414 | A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. | J Biomol Screen | 1999 | https://conductscience.org/library/papers/10838414 | PubMed |
| 2 | 18,388,863 | A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. | EMBO J | 2008 | https://conductscience.org/library/papers/18388863 | PubMed |
| 3 | 19,903,845 | Differential enhancement of breast cancer cell motility and metastasis by helical and kinase domain mutations of class IA phosphoinositide 3-kinase. | Cancer Res | 2009 | https://conductscience.org/library/papers/19903845 | PubMed |
| 4 | 20,029,424 | A census of amplified and overexpressed human cancer genes. | Nat Rev Cancer | 2010 | https://conductscience.org/library/papers/20029424 | PubMed |
| 5 | 18,239,126 | Cancer proliferation gene discovery through functional genomics. | Science | 2008 | https://conductscience.org/library/papers/18239126 | PubMed |
| 6 | 19,536,107 | Novel anticancer targets: revisiting ERBB2 and discovering ERBB3. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19536107 | PubMed |
| 7 | 2,218,183 | More powerful procedures for multiple significance testing. | Stat Med | 1990 | https://conductscience.org/library/papers/2218183 | PubMed |
| 8 | 11,553,815 | Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11553815 | PubMed |
| 9 | 20,049,735 | Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors. | EMBO Mol Med | 2009 | https://conductscience.org/library/papers/20049735 | PubMed |
| 10 | 20,453,858 | 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers. | Nat Struct Mol Biol | 2010 | https://conductscience.org/library/papers/20453858 | PubMed |
1 to 10 of 42
See all 42 referencesCited by84
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 123 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,068,645 | Genetically predicted TTK inhibition and its association with reduced breast cancer risk: a two-step Mendelian randomization study of potential gut microbiome mediation. | Clinics (Sao Paulo) | 2026 | https://conductscience.org/library/papers/42068645 | PubMed |
| 40,565,246 | The ADCK Kinase Family: Key Regulators of Bioenergetics and Mitochondrial Function and Their Implications in Human Cancers. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40565246 | PubMed |
| 37,533,462 | Synthetic lethal approaches to target cancers with loss of PTEN function. | Genes Dis | 2023 | https://conductscience.org/library/papers/37533462 | PubMed |
| 37,443,114 | BID expression determines the apoptotic fate of cancer cells after abrogation of the spindle assembly checkpoint by AURKB or TTK inhibitors. | Mol Cancer | 2023 | https://conductscience.org/library/papers/37443114 | PubMed |
| 37,346,953 | New cyclic glycolipids from Silene succulenta promote in vitro MCF-7 breast carcinoma cell apoptosis by cell cycle arrest and in silico mitotic Mps1/TTK inhibition. | RSC Adv | 2023 | https://conductscience.org/library/papers/37346953 | PubMed |
| 37,190,140 | The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37190140 | PubMed |
| 36,934,096 | Synthetic lethality of drug-induced polyploidy and BCL-2 inhibition in lymphoma. | Nat Commun | 2023 | https://conductscience.org/library/papers/36934096 | PubMed |
| 36,439,873 | Identification of the mitochondrial protein ADCK2 as a therapeutic oncotarget of NSCLC. | Int J Biol Sci | 2022 | https://conductscience.org/library/papers/36439873 | PubMed |
| 36,405,310 | Combined 3D-QSAR, molecular docking and dynamics simulations studies to model and design TTK inhibitors. | Front Chem | 2022 | https://conductscience.org/library/papers/36405310 | PubMed |
| 36,085,291 | Comparison of the mutational profiles of neuroendocrine breast tumours, invasive ductal carcinomas and pancreatic neuroendocrine carcinomas. | Oncogenesis | 2022 | https://conductscience.org/library/papers/36085291 | PubMed |
1 to 10 of 84
See all 84 cited byGenes41
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ADCK2 | 90,956 | PubTator's text mining | https://conductscience.org/library/genes/90956 | NCBI Gene |
| AKT1 | 207 | PubTator's text mining | https://conductscience.org/library/genes/207 | NCBI Gene |
| AKT2 | 208 | PubTator's text mining | https://conductscience.org/library/genes/208 | NCBI Gene |
| AKT3 | 10,000 | PubTator's text mining | https://conductscience.org/library/genes/10000 | NCBI Gene |
| AURKA | 6,790 | PubTator's text mining | https://conductscience.org/library/genes/6790 | NCBI Gene |
| BRAF | 673 | PubTator's text mining | https://conductscience.org/library/genes/673 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| CAMK1 | 8,536 | PubTator's text mining | https://conductscience.org/library/genes/8536 | NCBI Gene |
| CCND1 | 595 | PubTator's text mining | https://conductscience.org/library/genes/595 | NCBI Gene |
| CDK4 | 1,019 | PubTator's text mining | https://conductscience.org/library/genes/1019 | NCBI Gene |
1 to 10 of 41
See all 41 genesDrugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21984977
GET https://conductscience.org/api/papers/v1/21984977/authors?page=2